Affordable Access

gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.

Authors
  • Van Thiel, D H
  • Friedlander, L
  • Malloy, P
  • Wright, H I
  • Gurakar, A
  • Fagiuoli, S
  • Irish, W
Type
Published Article
Journal
Hepato-gastroenterology
Publication Date
Jan 01, 1995
Volume
42
Issue
6
Pages
888–892
Identifiers
PMID: 8847041
Source
Medline
License
Unknown

Abstract

Both the hepatic iron content of the liver and the gamma-glutamyl transpeptidase value prior to treatment were able to predict a clinical response to Interferon therapy. More importantly, the gamma-glutamyl transpeptidase level measured in serum could be used to monitor the IFN response during treatment and was found to predict clinical exacerbations of hepatitis following withdrawal of Interferon therapy.

Report this publication

Statistics

Seen <100 times